ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac
July 21, 2021Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China. -
Univercells Introduces Vaccine Manufacturing Platform
January 14, 2019Univercells announced the commercial launch of its proprietary NevoLine bioproduction system for vaccines. The system was initially developed as part of a $12 million Grand Challenges grant awarded by ..... -
Sinovac Announces Preliminary Results of Phase III Trial on sIPV
April 20, 2018Sinovac Biotech Ltd. today announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine ("sIPV") developed by Sinovac Biotech Co., Ltd. ("Sinovac Beijing") on the unblinding conference held on April 19, 2018.
Pharma Sources Insight January 2025
